Skip to main content

Clinical Drug Investigation

Ausgabe 5/2004

Inhalt (7 Artikel)

Review Article

Risk Reduction Strategies in Ischaemic Stroke

Mark J. Alberts, Richard Atkinson

Original Research Article

Cost of Heart Failure in Patients Receiving β-Blockers and Angiotensin-Converting Enzyme Inhibitors

William S. Weintraub, Hugh Kawabata, Michele Tran, Gilbert J. L’italien, Roland S. Chen

Original Research Article

Effect of Betamethasone-Loratadine Combination Therapy on Severe Exacerbations of Allergic Rhinitis

J. R. Snyman, P. C. Potter, M. Groenewald, J. Levin

Original Research Article

Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder

Ramy A. Mahmoud, Luella M. Engelhart, Carmela C. Janagap, Gerry Oster, Dan Ollendorf

Short Communication

Switch from Risperidone to Perospirone in Patients with Chronic Schizophrenia

Kazuyuki Fujita, Toshihiko Fukuchi, Shoji Yuasa, Eriko Inada, Yoko Tarao, Kousuke Kanemoto

Case Report

Toxic Epidermal Necrolysis Induced by a Triple-Drug Regimen for Helicobacter Pylori Eradication

Yoshihiro Matsukawa, Hiroyuki Hara, Masanori Aoki, Kentaro Inada, Motohide Kaneko, Ko Mitamura, Umihiko Sawada, Shigemasa Sawada, Takashi Horie, Toyoko Ochiai